Medication
Mint-Perindopril
DIN 02476762 · Mint Pharmaceuticals Inc Likely a generic
What it is
- Active ingredients
- Perindopril Erbumine — 2 mg
- Form and route
- Tablet · Oral
- Schedule
- PRESCRIPTION
- Authorised since
- 2019-03-22
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.
Products with the same active ingredient
- Coversyl
- Apo-Perindopril
- Auro-Perindopril
- Teva-Perindopril
- Sandoz Perindopril Erbumine
- PMS-Perindopril
- Riva-Perindopril
- Mar-Perindopril
- Perindopril Erbumine
- Perindopril Erbumine
- M-Perindopril Erbumine
- Perindopril Erbumine
- Nra-Perindopril
- Bio-Perindopril
- Jamp Perindopril Erbumine
- AG-Perindopril Erbumine
- NB-Perindopril
Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
How it is classified
- Anatomical main group
- Cardiovascular system
- ATC code
- C09AA04
The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of C09AA04, see the WHO ATC/DDD Index.
Recalls and safety alerts
Recall matching is not available yet.
RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.